tiprankstipranks
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD

Compare Tvardi Therapeutics (TVRD) vs. Competitors

2,524 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$2.90
$27.21M
-1.38
-80.13%
4 Buy
3 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$32.94M
-1.74
-75.61%
3 Buy
1 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$49.02M
5.20
-30.22%
Aligos Therapeutics
$8.00
$49.47M
-1.22
100.38%
3 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.45
$15.68M
-2.51
-82.39%
Adlai Nortye Ltd. Sponsored ADR
$11.16
$411.81M
489.23%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
2.90
-11.80
-80.27%
PSTV
Plus Therapeutics
4.80
-13.95
-74.40%
CUE
Cue Biopharma
0.50
-0.27
-34.60%
ALGS
Aligos Therapeutics
8.00
3.92
95.96%
GNTA
Genenta Science SpA Sponsored ADR
0.67
-2.98
-81.67%
ANL
Adlai Nortye Ltd. Sponsored ADR
11.16
9.22
475.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts